Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa Inhibition

For the complete activity, including supporting material, please visit https://www.peervoice.com/FBM860. Presented by Xin Cheng, MD, PhD; Ashkan Shoamanesh, MD, FRCPC; and Jeffrey Weitz, MD, OC, FRCPC. Learning Objectives: Explain the rationale and potential role for Factor XIa inhibition in secondary prevention of non-cardioembolic ischaemic stroke (NCIS) or high-risk transient ischaemic attack (TIA); Recall the trial design, methodology, and inclusion criteria for key phase 3 trials of Factor XIa inhibitors in secondary stroke prevention (SSP) of NCIS or high-risk TIA; Evaluate clinical outcomes for Factor XIa inhibitors in the prevention of ischaemic stroke following an acute NCIS or high-risk TIA .

Listen